摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Ni(1,4,7-trimethyl-1,4,7-triazacyclononane) | 33480-88-5

中文名称
——
中文别名
——
英文名称
Ni(1,4,7-trimethyl-1,4,7-triazacyclononane)
英文别名
——
Ni(1,4,7-trimethyl-1,4,7-triazacyclononane)化学式
CAS
33480-88-5
化学式
C21H20N2NiO4
mdl
——
分子量
423.091
InChiKey
AOUDAZSPUTWIFS-NIUDKRPCSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    描述:
    Ni(1,4,7-trimethyl-1,4,7-triazacyclononane) 在 triethylamine 作用下, 以 甲醇 为溶剂, 生成
    参考文献:
    名称:
    双(杂二核)[Cu II Ni II ] 2和线性异三核配合物Co III Cu II Ni II中的交换耦合。合成,结构与性能
    摘要:
    两种杂金属配合物[{Cu II(HLOX)Ni II(N 3)} 2 ]和[(tmtacn)Co III(μ-OH)Cu II(LOX)Ni II(OH 2)2 ] [ClO 4 ] 2( tmtacn = 1,4,7-三甲基-1,4,7-三氮杂环壬烷)包含相同的[Cu II Ni II ]核,嵌在不对称的二室中亚胺--肟 配体H 4 LOX已合成并表征。它们的晶体结构表明,Cu II位于N(肟)2 O(酚盐)2位置,并呈现平面几何形状。Ni II是六配位的,并结合到N 2 O 4供体阵列上,该供体阵列包含两个亚氨基氮,两个酚氧和两个轴向配位的H 2 O分子。钴(III)低自旋且六配位。在10 K的DMF溶液中,配合物的EPR光谱显示自旋双峰基态,“ g ”为“反”。 值表明未配对电子在CuNi核上的离域。在2-290 K范围内的磁化率测量结果证实顺磁性镍(II)和铜(II)中心是反铁磁耦合的,通过-115
    DOI:
    10.1039/a908426f
  • 作为产物:
    参考文献:
    名称:
    A rational assembly of a series of exchange coupled linear heterotrinuclear complexes of the type MAMBMC as exemplified by FeIIICuIINiII, FeIIINiIICuII and CoIIICuIINiII
    摘要:
    本文介绍了合理合成含有三种不同金属亚甲基溴联苯胺的线性三核络合物的一般方法,并通过 X 射线晶体学和磁感应强度测量对该系列的一个成员--FeIIICuIINiII 进行了表征。
    DOI:
    10.1039/a806575f
点击查看最新优质反应信息

文献信息

  • Synthesis, structures and magnetism of heterotrimetallic Ni–Cu–Ln complexes based on a dicompartmental imine–oxime ligand
    作者:Zhao-Xia Zhu、Li-Zheng Cai、Xiao-Wei Deng、Yan-Ling Zhou、Min-Xia Yao
    DOI:10.1039/c7nj01955f
    日期:——
    are embedded in the dicompartmental imine–oxime ligand of HL to form a [Ni(MeOH)(HL)Cu(MeOH)]+ cation, and the cation itself dimerizes via two oxime oxygen atoms coordinated to Ni(II) ions to form a centrosymmetric tetranuclear cluster of [Ni(MeOH)(HL)Cu(MeOH)]22+. LnIII ions are coordinated by four dbm− anions to form a [Ln(dbm)4]− unit as a balance anion. Magnetic susceptibility measurements show that
    四个Ni II -Cu II -Ln III杂三属配合物[Ni(MeOH)(HL)Cu(MeOH)] 2 [Ln(DBM)4 ] 2 · x CH 3 OH· y H 2 O(Ln = Gd,x = 4,ÿ = 2 1,Ln为Tb时,X = 6,ÿ为= 0 2,Ln为,X = 6,ÿ为= 0 3,Ln为何,X = 6,ÿ = 0 4,分别为H 4 L = N,Ñ N'-双(2-羟基-3-基-5-甲基苯基亚甲基)-1,3-丙二胺DBM - = 1,3-二苯基丙烷-1,3-二酮)的阴离子已经合成。结构分析表明,在所有配合物中,Ni II和Cu II离子均嵌入HL的二格亚胺-配体中,形成[Ni(MeOH)(HL)Cu(MeOH)] +阳离子,并且阳离子本身通过两个氧原子与Ni(II)离子配位形成[Ni(MeOH)(HL)Cu(MeOH)] 2 2+的中心对称四核簇。LN III离子由
  • Dinuclear copper(II), nickel(II) and mixed valence CuII-CuI complexes: influence of donor groups on redox behaviour of dicopper complexes
    作者:B. Srinivas、P.S. Zacharias
    DOI:10.1016/s0277-5387(00)83744-4
    日期:——
    Dinuclear copper(II) and nickel(II) complexes of hexadentate Schiff base ligands derived from 2,6-diformyl-4-methylphenol, 1,3-diaminopropane with various ortho and/or para substituted anilines have been synthesized and investigated for their magnetic and electrochemical properties. The dinuclear copper(II) complexes exhibit strong antiferromagnetic interactions between the metal centres (mu(eff)/copper atom = 0.98-1.10-mu(B)). For the nickel(II) complexes the interaction is weak (mu(eff)/nickel atom = 2.83-3.02 mu(B)). These complexes undergo sequential one-electron transfers at two different potentials. The first electron-reduction potential (E1) shifts to more negative values for copper(II) complexes having potential donor groups at the ortho position of the phenylazomethine ring. This has been attributed to the weak bonding interaction of these groups with the central metal ion. Analogous mononuclear copper(II) complexes with donor groups such as OMe, OEt and SMe are shown to give irreversible CV peaks. Mixed-valence Cu(II)-Cu(I) complexes of analogous para substituted anilines have been synthesized by chemical methods and the unpaired electron is found to be localized on one of the coppers.
  • Srinivas, Bhamidi; Zacharias, Panthappally S., Canadian Journal of Chemistry, 1992, vol. 70, # 12, p. 2906 - 2913
    作者:Srinivas, Bhamidi、Zacharias, Panthappally S.
    DOI:——
    日期:——
  • The synthesis, redox properties, and ligand binding of heterobinuclear transition-metal macrocyclic ligand complexes. Measurement of an apparent delocalization energy in a mixed-valent copper(I)copper(II) complex
    作者:R. R. Gagne、C. L. Spiro、T. J. Smith、C. A. Hamann、W. R. Thies、A. D. Shiemke
    DOI:10.1021/ja00404a017
    日期:1981.7
  • Magnetic and electrochemical studies of a series of homo- and hetero-dinuclear copper(II), nickel(II) and zinc(II) complexes
    作者:B. Srinivas、N. Arulsamy、P.S. Zacharias
    DOI:10.1016/s0277-5387(00)83284-2
    日期:1992.1
    Homo- and hetero-dinuclear copper(II), nickel(II) and zinc(II) complexes of a dinucleating ligand derived from the condensation of 2 mol of 2,6-diformyl-4-methylphenol and 1 mol of 1,3-diaminopropane (L) have been prepared as their perchlorate salts, and characterized and studied for their magnetic and redox properties. The homo-dinuclear copper(II) and nickel(II) complexes and the hetero-dinuclear complexes containing copper(II) and nickel(II) exhibit antiferromagnetic coupling at room temperature. A comparison of the redox behaviour of the zinc(II) containing hetero-dinuclear complexes with that of the homo- and hetero-dinuclear complexes containing copper(II) and nickel(II) shows that in most of the cases the exchange coupling influences the redox properties of the complexes.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫